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Abstract
Dyskeratosis congenita is an inherited disease caused by mutations in genes coding for
telomeric components. It was previously reported that expression of a dyskerin-derived
peptide, GSE24.2, increases telomerase activity, regulates gene expression and decreases
DNA damage and oxidative stress in dyskeratosis congenita patient cells. The biological
activity of short peptides derived from GSE24.2 was tested and one of them, GSE4, that
probed to be active, was further characterized in this article. Expression of this eleven
amino acids long peptide increased telomerase activity and reduced DNA damage, oxida-
tive stress and cell senescence in dyskerin-mutated cells. GSE4 expression also activated
c-myc and TERT promoters and increase of c-myc, TERT and TERC expression. The level
of biological activity of GSE4 was similar to that obtained by GSE24.2 expression. Incorpo-
ration of a dyskerin nuclear localization signal to GSE24.2 did not change its activity on pro-
moter regulation and DNA damage protection. However, incorporation of a signal that
increases the rate of nucleolar localization impaired GSE24.2 activity. Incorporation of the
dyskerin nuclear localization signal to GSE4 did not alter its biological activity. Mutation of
the Aspartic Acid residue that is conserved in the pseudouridine synthase domain present
in GSE4 did not impair its activity, except for the repression of c-myc promoter activity and
the decrease of c-myc, TERT and TERC gene expression in dyskerin-mutated cells. These
results indicated that GSE4 could be of great therapeutic interest for treatment of dyskerato-
sis congenita patients.
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Introduction
Telomere maintenance alterations are in the origin of an increasing number of diseases such as
dyskeratosis congenita, aplastic anemia or pulmonary fibrosis (recently reviewed by S.A. Sav-
age [1]). Telomeres are structures located at the end of the chromosomes that play essential
roles in chromosome replication and stability [2, 3]. The sequence of their DNA consists of
hundreds of repeats of the TTAGGGmotif. The DNA replication machinery cannot complete
the synthesis of the chromosome ends that is accomplished by a RNA-protein complex with
reverse transcriptase activity named telomerase [4]. The telomerase protein with reverse tran-
scriptase activity is encoded by the TERT gene and uses as template the RNAmolecule encoded
by the TERC (also named TR) gene that is another component of the telomerase complex [5].
A third essential component is dyskerin, encoded by the dkc1 gene [6, 7]. Additional compo-
nents of the telomerase complex include the proteins NOP10, GAR and NHP2 [8]. Telomeres
acquire a very specialized structure since the terminal region of the DNA stays single-stranded
and folds back to get inter winged with a close telomere region to form a circular structure (T-
circle) [9]. In addition, the telomere DNA binds to a specific protein complex, named shelterin
complex, which protects telomeres from degradation [10]. This structure also avoids the recog-
nition of telomeres as damaged DNA by the DNA-repair signalling system. The correct struc-
ture of the telomeres is therefore essential for the maintenance of chromosome integrity and
cell cycle progression [11]. Telomere shortening that occurs during proliferation of non-stem
or transformed cells results in genome instability, the fusion of chromosomes and induces apo-
ptotic cell death or senescence [11].
Mutations in the genes coding for components of the telomerase (TERT, TERC, DKC,
NOP10, NH2) or shelterin (TINF2) complexes cause a number of diseases known as telomero-
pathies or Telomere Biology Disorders. Among them are dyskeratosis congenita, premature
aging syndromes, aplastic anemia, pulmonary fibrosis and cancer (see Savage, S.A. [1] and
Glousker, G. et al [12] for recent reviews).
Dyskeratosis congenita is a rare disorder characterized by bone marrow failure and
increased susceptibility to cancer [13]. Mutations in DKC1 produce the predominant X-linked
form of this disease. The encoded protein, dyskerin, is a pseudouridine synthase required for
the postranscriptional modification of ribosomal, small nuclear and nucleolar RNAs and some
mRNAs [7, 14] [15, 16]. In addition, is an essential component of the telomerase complex as
previously indicated. Dyskerin has three conserved domains, the Dyskerin Like Domain
(DKLD), the pseudouridine synthase domain (TRUB domain) and the RNA binding domain
(PUA domain) [7]. Mutations in these domains produce X-linked dyskeratosis congenita [7,
17]. We have previously described that a 55 amino acids-long fragment of the dyskerin TRUB
domain, named GSE24.2, has protective effects on cells derived from dyskeratosis congenita
patients [18]. GSE24.2 treatment increases telomerase activity of patient cells. This peptide also
protects cells from treatment with the anticancer drug cisplatin, that induces intra- and inter-
strand DNA bridges, and from telomerase inhibitors. Expression of GSE24.2 from plasmid or
viral vectors or direct transfection of cells with the peptide, produced in bacteria or chemically
synthesized, have similar effects [19]. GSE24.2 increases TERT and c-myc expression through
transcriptional activation and stabilizes TERC RNA in dyskerin mutant cells [19]. This peptide
protects cells from basal DNA damage, which is increased in dyskeratosis congenita patients
[20]. These activities make of GSE24-2 a good candidate for a therapeutic approach to dyskera-
tosis congenita and related telomeropathies. Actually, the EMA recently approved GSE24.2 as
an orphan drug for dyskeratosis congenita treatment (EU/3/12/1070-EMA/OD/136/11).
In this article we describe that a smaller peptide of just eleven amino acids, named GSE4,
corresponding to the N-terminal region of GSE24.2, maintains the same capacity to regulate
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gene expression, to protect cells from DNA damage and to decrease oxidative stress as
GSE24.2. In addition, GSE24.2 and GSE4 protect dyskeratosis congenita patient’s cell from
cell senescence.
Materials and Methods
Cell culture and transfection
The previously described F9 and dyskerin-mutated F9 cells (F9-A353V) [19, 21], were cultured
in Dulbecco Modified Eagle Medium (DMEM) supplemented with 10% foetal bovine serum, 2
mM glutamine (Gibco) and 1.5 gr/ml of sodium bicarbonate. HEK293T cells (ATCC) were cul-
tured in DMEMmedia supplemented with 10% foetal bovine serum and 2 mM glutamine.
DC-C and DC-3 cells (Coriell Cell Repository) were cultured in Roswell Park Memorial Insti-
tute (RPMI) media supplemented with 20% foetal bovine serum and 2 mM glutamine. XDC-
1787-C (Corriel Cell Repository) and F26IIB cells (generated in our laboratory), were cultured
in Minimum Essential Medium Eagle (MEM) media supplemented with 15% foetal bovine
serum and 2 mM glutamine. Cells were transfected with 10 μg of DNA/106 cells using lipofec-
tamine plus (Invitrogene, Carlsbad, USA) or the K2 transfection kit (Biontex Lab, Planegg/
Martinsried, GE) according to the manufacturers’ instructions. 15 μg of peptides per 35 mm
dish were transfected using the ProteoJuice Protein Transfection Reagent (Merck Millipore,
Billerica, MA, USA) or the K2 transfection kit.
Peptide production and purification
The GSE24.2 peptide was produced in E. coli DH5α transformed with pGATEV GSE24.2 as
previously described [20]. HPLC-purified synthetic peptides were obtained from Peptide 2.0
Inc (Chantilly, USA) and China Peptides Co. Ltd. (Shanghai, China).
Vector constructions and in vitro mutagenesis
The localization signal KRKR (amino acids 446–449) was incorporated to the 3’ end of the
GSE 24.2 expression vector by PCR using the oligonucleotides 5’-GGGAATTCTGGTTTGAT
TAATCTTGACAAGC-3’ and 5’-GGTCTAGACTCGCTTCCGCTTCTTCACCAAGCGAG
TGGCTCG-3’. The amplified product was cloned between the EcoRI and XbaI sites of the
pcDNA3-myc vector to generate the GSE24.2-NLS1.3 vector. The localization signal
KKEKKKSKK (amino acids 467–476) was introduced using the oligonucleotides: 5’-GGGAAT
TCTGGTTTGATTAATCTTGACAAGC-3’ and 5’-GGTCTAGACCTTCTTACTCTTCTTCT
TTTCCTTCTTCTTCACCAAGCGAGTGGCTCG-3’ and cloned in pcDNA3-myc to generate
GSE24.2-NLS2.3. The fragments GSE24.2, GSE24.2-NLS1.3 and GSE24.2-NLS2.3 were also
cloned in the pRRL-CMV-IRES-GFP vector using the PstI and BamHI restriction sites. GSE4
and derived fragment were cloned between the PstI and BamHI restriction sites of pRRL-CMV
as double-stranded oligonucleotides obtained by hybridization of the following oligonucleo-
tides: GSE4, 5’-GATGGGTTTCATTAATCTTGACAAGCCCTCTAACCCCTAAG-3’ and 5’-
GATCCTTAGGGGTTAGAGGGCTTGTCAAGATTAATGAAACCCATCTGCA-3’; GSE4-
NLS1: 5’-GATGGGTTTCATTAATCTTGACAAGCCCTCTAACCCCAAGCGGAAGCGAT
AAG-3’ and 5’-GATCCTTATCGCTTCCGCTTGGGGTTAGAGGGCTTGTCAAGATTAAT
GAAACCCATCTGCA-3’; GSE4-NLS1-DA (incorporating the GAC to GCC change): 5’-
GATGGGTTTCATTAATCTTGCCAAGCCCTCTAACCCCAAGCGGAAGCGATAAG-3’
and 5’-GATCCTTATCGCTTCCGCTTGGGGTTAGAGGGCTTGGCAAGATTAATGAAAC
CCATCTGCA-3’.
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Gene-reporter assays
Cells were transfected with 10 μg/106 cells of expression vectors for GSE24.2, GSE4 and derived
peptides and the corresponding luciferase reporter vectors (1 μg/106 cells). The TERT and c-
myc (px3.2) promoter constructs have been described previously [18, 22]. Twenty four hours
after transfection protein extracts were prepared and luciferase activity determined using a
commercial kit (Promega Corporation, Madison, WI, USA). Luciferase activity was expressed
as arbitrary units by μg of protein concentration, determined with the Bradford Reagent
(BioRad, Berkeley, CA, USA).
Immunofluorescence and immunocytochemistry
Cells were grown on coverslips, fixed, permeabilized and incubated with the corresponding
antibodies as previously described [20]. Nucleoli were stained incubating the cells for 20 min
with 0,5 μM of the SYTO RNA Select Green Fluorescent Cell Stain (Molecular Probes). DNA
damage foci were identified by the presence of γH2AX as previously described [20]. Oxidative
stress was determined using the anti-8-oxoguanine antibody, clone 483.15 (MAB3560, Merck-
Millipore). Images were acquired using a Zeiss Confocal microscope and processed using ZEN
2011 Light Edition and ImageJ software. DNA synthesis was determined by immunocytochem-
istry using anti-Ki67 antibodies (RM9106-50; NeoMarkers Inc. Fremont, CA, USA).
Telomeric Repeat Amplification Protocol (TRAP) assay
The TRAPeze kit (Millipore, Billerica, MA, USA) [23] was used to determine telomerase activ-
ity. The activity of each sample was normalized using the internal control provided in the kit.
Determination of reactive oxygen species (ROS) content with
dihydroethidium
Cells were washed 2 times with pre-warmed PBS medium, dihydroethidium (Dihydroethi-
dium, D7008-Sigma, St. Louis, MI. USA) was added and the cells incubated at 37°C for 25 min.
The fluorescence was measured using FACS SCAN II (BD, USA), with 530 nm of excitation
wavelength and 630 nm of emission wavelength.
Determination of cell senescence
Cells were plated on 6-well plates at a density of 1x104 cells/well. After 4 days of culture cells
were fixed and the acid-β-galactosidase activity detected using the Senescence Detection Kit
(BioVision, USA). Six images were taken from each well using a Nikon Eclipse TS100 micro-
scope (Nikon, USA) and the percentage of senescent cells calculated for each of them.
Protein expression analyses
Whole-cell extracts were obtained and analyzed by Western blot as previously described [24].
Antibodies
Primary antibodies used for γH2AX and phosporylated Chk2 detection were from Cell Signal-
ling Technology (2577, Cell Signalling Technology, Danvers, MA, USA), and those used for α-
tubulin detection from Sigma-Aldrich (T9026, Sigma-Aldrich, St. Louis, MO, USA). Secondary
antibodies were purchased from BioRad (Berkeley, CA, USA) and Cell Signalling Technology.
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Quantitative RT-PCR analyses of gene expression
Total RNA was obtained from the cell cultures using the Trizol Reagent (Invitrogen, Carlsbad,
CA, USA). One microgram of RNA was converted to cDNA using random primers and the
High-Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA). Quantitative
PCR was done using the Power SYBR Green kit (Applied Biosystems, Foster City, CA, USA).
The programs used have been described by Machado-Pinilla, et al. [19]. SOD1(Cu/Zn SOD)
and SOD2 (Mn SOD) mRNA levels were determined using the TaqMan Universal PCR Mas-
ter Mix. The StepOne Plus Real Time PCR System (Applied Biosystems, Foster City, CA,
USA) was used for analyses of the PCR products. Relative gene expression was calculated
according to the comparative threshold cycle method [25] using β-actin as endogenous
control.
Primers used for quantitative RT-PCR
The following primers were used: m-cmyc-S: 5’-GAGCTGTTTGAAGGCTGGATTT-3’;
m-cmyc-AS: 5’-TCCTGTTGGTGAAGTTCACGTT-3’; m-TERT-S: 5’-AGATCAAGAGCAG
TAGTCGCCAG-3’; m-TERT-AS: 5’-TTTACAGCACACCGACCCAGAG-3’; m-TR-S: 5’:
GCTGTGGGTTCTGGTCTTTTGTTC-3’; m-TR-AS: 5’-CGTTTGTTTTTGAGGCTCGGG-
3’; β-actin-S: 5’- GGTATGGAATCCTGTGGCATCCATGAAA-3’; β-actin-AS: 5’-GTGTA
AAACGCAGCTCAGTAACAGTCCG-3’.
Statistical analyses
Experiments were repeated, at least, three times with triplicate samples. Statistical significance
was calculated using the Unpaired t-test (two- tailed). The significance has been considered at
p<0.05, p<0.01 and p<0.001. GraphPad software v5.0 was used for statistical analysis
and graphic representations.
Results
1. Functional study of the GSE24.2-derived peptide GSE4 on DNA
damage rescue, telomerase activity and cell proliferation in dyskeratosis
congenita cells
Many of the previous functional studies were done with GSE24.2 peptides produced in E.
coli. The analysis of these preparations by mass spectroscopy indicated the presence of sev-
eral smaller peptides probably originated by GSE24.2 partial degradation. The more abun-
dant peptide was an eleven amino acids long peptide corresponding to the N-terminal region
of GSE24.2 (GSE4, Fig 1A). The functional activity of this peptide was compared to that of
GSE24.2 in several analyses. We have previously reported that the GSE24.2 peptide reduced
DNA damage [20]. We transfected F9 or the F9-derived dyskerin-mutant F9A353V cells
with pRRL-CMV-IRES-GFP vector, either empty (vector) or expressing GSE24.2 or GSE4 to
study their possible effect on basal DNA damage by measuring γH2AX phosphorylation (Fig
1A). We found that the amount of γH2AX in F9A353V cells decreased to similar levels after
transfecting both peptides (40 and 30%, respectively). The possible effect of GSE4 expression
on telomerase activity was assayed on the fibroblastoid cell line F26IIB, derived from a dys-
keratosis congenita patient carrying the Ala2Val hemizygous mutation [26]. Cells were
transfected with the above-mentioned vectors and their telomerase activity determined, as
shown in Fig 1B. Quantification of the extension products indicated a significant increase in
telomerase activity upon GSE24.2 and GSE4 expression. The proliferation capacity of the
transfected cells was estimated by the expression of the Ki67 nucleolar protein, as shown in
GSE4 Activity on Dyskeratosis Congenita Cells
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Fig 1. DNA-damage protective effect, telomerase activation and cell proliferation induction of one
small peptide, GSE4, derived fromGSE24.2. Panel A. One small peptide derived from GSE24.2, GSE4,
and GSE24.2 were expressed in F9_A353V cells that were transfected with the pRRL-CMV-IRES-EGFP
vector, either empty (Vector) or expressing GSE24.2 or GSE4. Twenty four hours later cells were lysed and
the presence of γH2AX and α-tubulin (loading control) analyzed by western blot. Un-transfected F9 and
F9-A353V cells were used as controls. The values at the bottom of the panel indicate the estimated ratio
between γH2AX and α-tubulin expression levels referred to those found in cells transfected with the empty
vector (F9-A353V vector). The amino acid sequences of GSE24.2 and GSE4 are indicated at the lower part
GSE4 Activity on Dyskeratosis Congenita Cells
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Fig 1C. A significantly higher percentage of cells expressing GSE24.2 and GSE4 were positive
for Ki67 expression, indicative of higher proliferation rates.
2. Oxidative stress and senescence are decreased in X-DC cells by
GSE4 expression
Oxidative stress is one of the causes of DNA damage producing both single-strand breaks
(SSBs) and double-strand breaks (DSBs). Cells obtained from dyskeratosis congenita patients
showed high levels of oxidative stress and reactive oxygen species (ROS) production that
decreased upon treatment with GSE24.2 [20]. We therefore tested the activity of GSE4 on oxi-
dative stress on a cellular model of dyskeratosis congenita. Oxidative stress was first deter-
mined by the presence of α-8-oxoguanine on the cellular DNA. F9-A353V cells were
transfected with the pRRL-CMV-IRES-GFP vector expressing GSE24.2, GSE4 or the empty
vector and the amount of α-8-oxoguanine present on the cells determined by immunohis-
tochemistry. F9 cells that do not carry any DKC mutation were used as control. The quantifi-
cation of α-8-oxoguanine expression is shown in Fig 2A. Expression of GSE24.2 and GSE4
decreased α-8-oxoguanine levels of F9-A353V cells. Oxidative stress was also measured in
cells derived from dyskeratosis congenita patients (DC-3, carrying the Thr66Ala mutation in
dkc1) and healthy relatives (DC-C) by determining ROS levels using dihydroethidium, as
shown in Fig 2B. Dyskeratosis- congenita patient cells infected with the empty vector showed
higher levels of ROS than those of the healthy controls. Expression of GSE24.2 and GSE4 in
the patient cells significantly decreased ROS levels. ROS production is associated with
decreased expression of antioxidant enzymes such as the Cu/Zn- and Mn-dependent Super-
oxide Dismutases (SOD) [20]. The expression levels of the mRNAs coding for these two
enzymes was determined by RT-qPCR, as shown in Fig 2C. Patient cells expressing the empty
vector (DC-3 vector) showed decreased levels of both mRNAs, as compared to cells from the
healthy control (Control cells). Expression of GSE24-2 and GSE4 greatly increased Cu/Zn
SOD and Mn SOD mRNA expression levels in agreement with their capacity to decrease ROS
production.
Telomere shortening has been described to result in cell senescence [27]. Therefore, the pos-
sible effect of GSE24.2 and GSE4 expression in senescence of dyskeratosis congenita patient’s
cells has been studied. One fibroblastoid cell line established from a dyskeratosis congenita
patient (F26IIB) was transfected with the pRRL-CMV-IRES-GFP vector, either empty or
expressing GSE24.2 or GSE4. After four days of culture senescent cells were identified by the
expression of acidic β-galactosidase and the percentage of senescent (SA-β-gal) cells deter-
mined, as shown in Fig 2D. A fibroblastoid cell line established from a healthy relative of a DC
patient (XDC-1787-C) was used as internal control. Expression of GSE4 and GSE24.2 signifi-
cantly decreased cell senescence.
of the panel. Panel B. The telomerase activity of F26IIB cells transfected with the pRRL-CMV-IRES-GFP
vector empty (vector), expressing GSE24.2 (GSE24.2) or GSE4 (GSE4) was determined using the Telomeric
Repeat Amplification Protocol (TRAP) assay. The amplification products obtained using three decreasing
amounts of cell extracts for each cell line are shown in the right panel. Quantification of the amplification
products, normalized to the internal control provided in the assay (indicated by an arrow at the right panel) is
shown in the left panel. Panel C. Expression of Ki67 was determined by immunocytochemistry in F26IIB cells
transfected as described in panel B. The percentage of cells expressing Ki67 is represented for each type of
transfected cells. The experiments were repeated three times with similar results. Asterisks indicated the
statistical significance (* p<0.05, **p<0.01, ***p<0.001).
doi:10.1371/journal.pone.0142980.g001
GSE4 Activity on Dyskeratosis Congenita Cells
PLOS ONE | DOI:10.1371/journal.pone.0142980 November 16, 2015 7 / 17
Fig 2. Effects of GSE24 and GSE4 peptides on oxidative stress and cell senescence. Panel A.
F9-A353V cells were transfected with the pRRL-CMV-IRES-EGFP vector empty (Vector), expressing
GSE24.2 (GSE24.2) or GSE4 (GSE4) (10 μg DNA per million cells). After 24 hours of transfection cells were
fixed and incubated with an anti-α-8-Oxoguanine antibody. The amount of antibody bound was determined
using a Zeiss Confocal microscope and quantified with the ImageJ program. Untransfected F9 and F9-A353V
cells were used as controls. Average α-8-Oxoguanine expression and standard deviations are shown. Panel
B. The amount of Reactive Oxygen Species (ROS) of control cells derived from healthy relative controls
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3. Requirement of nuclear and nucleolar localization signals for
GSE24.2 and GSE4 biological activity
Dyskerin is a nucleolar protein and different cellular localization regions have been described
[28]. Two of them were analyzed because their deletion or mutation altered the subcellular
localization of dyskerin [28]. The first one (KRKR, named NLS1 in this article) is required for
nuclear import while the second one (KKEKKKSKK, NLS2) increases the rate of nuclear and
nucleolar import. Since GSE24.2 does not contain any of these regions, both were indepen-
dently incorporated to the C-terminal region of the peptide to determine their possible contri-
bution to the cellular localization and activity of the peptide. We used plasmid expression
vectors with an N-terminal 6xmyc epitope (pcDNA3-myc). Cellular localization was studied
by immunohystochemistry using α-myc antibodies after their expression in HeLa cells (Fig
3A). In some of these experiments nucleoli were identified using the specific SYTO RNA Select
probe (Fig 3A, lower panels). The results showed that NLS1 incorporation increased the
nuclear localization of GSE24.2, with low expression in nucleoli. In contrast, NLS2 incorpo-
ration resulted in an even expression in all nuclear regions. NLS1 and NLS2 incorporation to
the N terminal region of GSE24.2 did not change the cellular localization (S1 Fig).
The functionality of the fusion peptides was determined by expressing them from the
pcDNA3-myc vector in F9-A353V, F9 and HEK293T cells. We have previously described that
expression of GSE24.2 activated TERT and c-myc promoters [18] [29]. Therefore, we studied
the activity of the different constructions on the human c-myc and TERT promoters (Fig 3B).
Both GSE24.2 and GSE24.2-NLS1.3 activated c-myc and TERT promoters in the three cell
lines analyzed to similar levels although some of the activity increases were not statistically sig-
nificant in F9 cells. However, GSE24.2-NLS2.3 only activated the TERT promoter. The effects
of GSE24.2-NLS2.3 on the c-myc promoter were variable, a significant increase was observed
in HEK293T cells and a significant decrease in F9 cells. None of the localization signals
improved the transcriptional activity of GSE24.2. The possible activity on DNA damage was
also studied using F9-A353V cells. The amount of DNA damage was estimated by evaluating
the expression levels of phosphorylated γH2AX and Chk2Thr68 proteins. Quantification of
DNA damage was made by Western blot using anti γH2AX and p-Chk2Thr68 antibodies (Fig
3C). In addition, the localization of DNA damage foci was observed by immunohistochemistry,
evaluating the amount of γH2AX-associated foci/cell (Fig 3D). GSE24.2 expression rescued the
cells from DNA damage decreasing 40 and 30% respectively of γH2AX and p-Chk2 levels (Fig
3C), as previously described [20]. NLS1.3 incorporation did not alter GSE24.2 activity while
addition of NLS2.3 partially impaired this activity (Fig 3C and 3D).
The nuclear localization signal NLS1 was also added to the C-terminus of GSE4 to deter-
mine their possible influence on the activity of the peptide. GSE4 is similar to the conserved
(DC-C) and cells derived form a dyskeratosis congenita patient (DC-3) infected with the
pRRL-CMV-IRES-EGFP vector, either empty (DC-3 vector) or expressing GSE24.2 (DC-3 GSE24.2) or
GSE4 (DC-3 GSE4) was determined using dihydroethidium (DHE). The average percentage of cells with
high intensity of DHE and standard deviation are represented. Panel C. Cells obtained from dyskeratosis
congenita patients and healthy relatives were transfected as described in panel B. The expression of the
mRNAs coding for Cu/Zn Superoxide dismutase (CuZnSOD) and Mn Superoxide dismutase (MnSOD) were
determined by quantitative RT-PCR. Panel D. The presence of senescent cells in the cell cultures was
determined by the assay of the β-Galactosidase activity using the X-Gal substrate. Fibroblasts obtained from
a dyskeratosis congenita patient (F26IIB) were transfected as described above using the empty vector
(F26IIB vector) or those expressing GSE24.2 (F26IIB GSE24.2) or GSE4 (F26IIB GSE4). Control cells
isolated from a healthy relative (XDC-1787C) were used as control. The percentage of cells expressing β-
Galactosidase activity (SA-β-gal) is represented for each cell line. Average values and standard deviations
obtained from three different experiments are represented. Statistical significance: * p<0.05, **p<0.01,
***p<0.001.
doi:10.1371/journal.pone.0142980.g002
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Fig 3. Functional analyses of GSE24.2-derived peptides containing nuclear localization signals. Panel A, cellular localization of the peptides. HeLa
cells were transfected with pcDNA3 vectors expressing GSE24.2, GSE24.2-NLS1.3 and GSE24.2-NLS2.3 peptides fused to a N-terminal 6xmyc epitope,
fixed, permeabilized and incubated with a c-myc antibody. Immunofluorescence staining of c-myc (green in top and red in the lower panels) was observed.
Additionally, nucleoli were stained using 500 nM of the SYTO RNA Select Green (green in lower panels). Arrows indicate the position of nucleoli. Panel B,
GSE4 Activity on Dyskeratosis Congenita Cells
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pseudouridine synthase active centre of other enzymes, where the Aspartic acid homologous to
the one present at position 6 in GSE4 is always conserved [30]. Therefore, this Aspartic acid
was changed to Alanine to test its possible functional relevance. These different peptides were
either chemically synthesized or expressed in the cells from plasmid or lentiviral vectors, as
indicated in each specific experiment.
The cellular localization of the GSE4 and GSE4-NLS1 peptides was studied by transfecting
fluorescein-labelled peptides into HeLa cells. Both peptides showed a predominant cytoplasmic
localization, as shown in Fig 4A, although the incorporation of NLS1 increased the presence of
the peptide in the perinuclear region. The biological activity of the peptides was determined by
expressing them from the lentiviral vector pRRL-CMV-IRES-GFP in different cell lines. Tran-
scriptional activity was determined by using the previously mentioned reporter vectors con-
taining the human c-myc and TERT promoters. The results obtained in F9-A353V, F9 and
HEK293T cells are shown in Fig 4B. GSE24.2 activity was also determined to further compare
the activity of the diverse peptides. GSE4 and GSE4-NLS1 peptides showed similar capacity
than GSE24.2 to activate c-myc and TERT promoters in the cell lines analyzed, including
the F9-A353V mutant cells. In HEK293T cells GSE4 and GSE4-NLS1 peptides were more
active than GSE24.2 but that was not the case in F9 and F9-A353V cells. The mutated
GSE4-NLS1-DA peptide was also active in these assays, with the exception of the c-myc
promoter in F9-A353V cells where the activity was actually decreased, indicating that this
Aspartic acid residue is not required for GSE4 activity. The activity of GSE4-NLS1-DA was,
however, lower than that of GSE24.2, GSE4 and GSE4-NLS1 in F9-A353V cells. The addition
of the nuclear localization signal NLS1 to GSE4 resulted in increased TERT promoter activity
in the three cell lines analyzed (Fig 4B).
The expression of c-myc and TERT mRNAs, and TERC (TR) RNA, in transfected
F9-A353V cells was determined by Reverse Transcription and quantitative PCR (Fig 4C). The
results obtained are in general agreement with the reporter expression analyses (Fig 4B).
GSE24.2, GSE4 and GSE4-NLS1 induced c-myc, TERT and TERC (TR) expression while
GSE4-NLS1-DA repressed the expression of these RNAs in F9-A353V cells. GSE4 was more
efficient in inducing TERT and less efficient in inducing TERC (TR) than GSE24.2 and
GSE4-NLS1 in these experiments.
The possible effect of the expression of GSE4 and derived peptides on DNA damage was
also studied. F9-A353V cells were transfected with the expression vectors mentioned above.
The amount of DNA damage in transfected cells was determined by quantification of γH2AX-
associated foci/cell (Fig 5A and 5B). In addition, Western blot analyses allowed the quantifica-
tion of γH2AX and p-Chk2Thr68 expression (Fig 5C). GSE4 and GSE4-NLS1 showed a
protective effect on DNA damage similar to that of GSE24.2 in both assays. The mutant
GSE4-NLS1-DA did not protect F9 A353V cells from DNA damage to the same extend under
these experimental conditions. Altogether our results indicated that the functional activity of
effect of pcDNA3_GSE24.2, GSE24.2_NLS13 and GSE24.2_NLS23 on the activity of c-myc and TERT promoters in F9_A353V, F9 and 293T cells. These
three cell lines were cotransfected with pcDNA3 empty vector (Vector), GSE24.2 and GSE24.2-derived constructions (10 μg DNA/106 cells) and c-myc-luc-
or hTERT-luc -reporter vectors (1 μg/106 cells). Luciferase activity was measured following 24 hours of transfection. Data were normalized by protein
concentration and referred to the empty vector. Data points represent the mean and standard deviations of 3 experiments performed in triplicate (statistical
significance: * p<0.05, **p<0.01, ***p<0.001). Panels C, D, analyses of cellular DNA damage. (C) F9_A353V cells were transfected with the
pRRL-CMV-IRES-EGFP empty vector (Vector), or expressing GSE24.2, GSE24.2-NLS13 and GSE24.2-NLS23 (10 μg DNA/106 cells). After 24 hours of
transfection cells were lysed and the amount of γH2AX, α-tubulin (loading control), phosphorylated Chk2 (p-Chk2) and total Chk2 (Chk2) analyzed by
western blot. The relative amounts of γH2AX/α-tubulin and p-Chk2/Chk2, normalized to the relation obtained for cells transfected with the empty vector, are
indicated under each blot. (D) Upper panel. F9_A353V cells were transfected with the vectors indicated above and the presence of γH2AX analyzed by
Immunofluorescence (red). Nuclear DNA was counterstained with DAPI (blue). Lower panel. Percentage of nuclei containing 0–9, 10–29 or more than 30 foci
of γH2AX. More than 200 cells were analyzed for each transfection. Experiments were repeated 3 times with similar results. Asterisks indicate the statistical
significance in relation to cells transfected with the empty vector (vector).
doi:10.1371/journal.pone.0142980.g003
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Fig 4. Cellular location and effect of GSE4 and derived peptides on promoter activity and gene
expression. Panel A. HeLa cells were transfected with 15 μg of fluorescein-labelled GSE4 and GSE4_NLS1
peptides (green), fixed and visualized by confocal microscopy (left panels). DNA was counterstained with
DAPI (blue, middle panels). Merged images are shown at the right panels. Panel B, promoter activity.
F9-A353V, F9 and 293T cells were co-transfected with the pRRL-CMV-IRES-EGFP vector, either empty
(Vector) or expressing the GSE24.2, GSE4, GSE4-NLSI or GSE4-NLS1-DA peptides (10 μg DNA/106 cells)
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GSE4 peptide was similar to that GSE24.2 in all the biological assays performed in dyskeratosis
congenita cells. Besides the addition of nuclear locations signals did not significantly increase
the transcriptional activity of these peptides or their protection to DNA damage. In addition,
the GSE4 Aspartic acid residue conserved in the pseudouridine synthase active centre of other
enzymes, although not essential, is required for maximal activity of the peptide on dyskerin-
mutant cells.
Discussion
Telomere biology disorders, including dyskeratosis congenita, are characterized by the progres-
sive shortening of the telomeres and by a number of cellular responses. In particular, telomere
shortening and/or low telomerase activity induces in the cells a DNA damage response [31],
and oxidative stress [32]. Therefore, the p53-dependent DNA damage response pathway is
activated resulting in cell cycle arrest and cellular senescence [33, 34]. These responses have an
important contribution to the pathology of the diseases through the deprivation of stem cells in
the more proliferative tissues. We describe in this article that a dyskerin-derived peptide of
eleven amino acids (GSE4) increases telomerase activity and decreases oxidative stress and the
DNA damage response in cellular models of dyskeratosis congenita. Expression of GSE4 also
regulates the global response of dyskeratosis congenita cells, increasing cell proliferation and
reducing cellular senescence. A fibroblastoid cell line derived from a patient carrying the Ala2-
Val mutation in dkc1(patient 26 in ref [26]) was used for these studies.
The results described in the present article confirm those previously shown for the 55
amino acids long fragment of dyskerin, GSE24.2, that contains GSE4. GSE24.2 increases telo-
merase activity and decreases oxidative stress and the DNA damage response in dyskeratosis
congenita patient cells [18, 19]. In addition, GSE4 protects F9-A353V dyskerin-mutant mouse
cells from DNA damage and reduces oxidative stress, also as GSE24.2 [20]. Furthermore, we
show in this article that GSE24.2 also increases cell proliferation and decreases cell senescence,
which had not been reported previously. Therefore, we show that GSE4 presents the same bio-
logical activity than the longer peptide GSE24.2, which has been approved as an orphan drug
for the treatment of dyskeratosis congenita. However, GSE4 presents some advantages over
GSE24.2, derived from its smaller size. One of them is the lower cost of chemical synthesis. In
addition, it could be easier to deliver into the cells. It would be also easier to develop variants
that could have improved pharmaceutical characteristics.
The data presented also provide information about the mechanisms of action of these pep-
tides. GSE4 increases telomerase activity in DKC1-mutated F9-A353V cells, increases expres-
sion of c-myc and the TERT and TERC telomerase components and the activity of TERT and
c-myc promoters, as previously reported for GSE24.2 [19]. The activity of the TERT promoter
has been shown to be higher in cancer cell lines than in transformed cells lines similar to those
used in the present study [35] therefore, the possible effects of GSE4 on TERT expression in
tumour cells should be tested in future studies. The structural studies indicate that GSE24.2
and c-myc-luc reporter or TERT-luc reporter vectors (1 μg/106 cells). Luciferase activity was measured 24
hours after transfection. Data were normalized by protein concentration and referred to the activity of the
control vector. Data points represent the mean and standard deviations of 3 experiments performed in
triplicate. Panel C, F9-A353V cells were transfected with vectors indicated on panel B. Total RNA was
extracted 24 h later and the levels of c-myc, TERT and TR(TERC) expression determined by reverse
transcription and quantitative PCR. Expression levels were normalized by β-actin expression and referred to
the expression levels of the cells transfected with the empty vector (Vector). The data shown represent the
mean and standard deviations of 3 experiments performed in triplicate. Statistical significance: * p<0.05,
**p<0.01, ***p<0.001.
doi:10.1371/journal.pone.0142980.g004
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and GSE4 do not require nuclear localization signals for activity. The incorporation of nuclear
or nucleolar localization signals to GSE24.2 increase nuclear or nucleolar localization but the
transcriptional activity of the peptide and the protective role on DNA damage are not
increased. Actually, the incorporation of the nucleolar localization signal NLS2 decreases
GSE24.2 activity. The GSE4 peptide containing a nuclear localization signals (GSE4-NLS1)
also show a biological activity similar to that of GSE4. These observations do not discard a
Fig 5. DNA damage protection by the expression of GSE4 and derived peptides. Panel A, F9-A353V
cells were transfected with the pRRL-CMV-IRES-EGFP vector, either empty (vector), or expressing
GSE24.2, GSE4, GSE4-NLS1 or GSE4_NLS1-DA (10 μg DNA/106 cells). After 24 hours of transfection cells
were fixed and incubated with anti γH2AX and a red-labeled secondary antibody. Nuclear DNA was
counterstained with DAPI (blue). Panel B, the amount of γH2AX-expressing foci shown on panel A was
determined. The percentage of cells containing 0 to 9, 10 to 29 or more than 30 foci is indicated. More than
200 cells were analyzed in each cell line. Experiments were repeated 3 times with similar results. Panel C,
F9_A353V cells were transfected with the plasmids indicated on panel A. Twenty four hours after transfection
cells were lysed and the expression of γH2AX, α-tubulin (loading control)(left panel) phosphorylated Chk2 (p-
Chk2) and total Chk2 (Chk2)(right panel) analyzed by western blot. Numbers under each blot indicate the
relative ɣH2AX/α-tubulin and p-Chk2/Chk2 expression normalized in relation to cells transfected with the
empty vector (statistical significance: * p<0.05, **p<0.01, ***p<0.001).
doi:10.1371/journal.pone.0142980.g005
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nuclear function for GSE24.2 or GSE4 since the localization experiments indicate that GSE24.2
and GSE4, at a lower extend, are present both at the nucleus and the cytoplasm in the absence
of nuclear localization signals, probably due to their small size.
Expression of GSE24.2 and GSE4 produces biological effects on several cell types expressing
either Wild type or mutated dyskerin indicating that these peptides do not just complement
dyskerin mutations. They seem to play several roles in the cell. It would be interesting to deter-
mine if there is a common mechanism for these activities or not. The data reported in this arti-
cle indicate that some peptide variants differ in their activities depending on the assay and/or
cell type studied. For example, GSE24.2-NLS2.3 activates TERT promoter at the same extend
as GSE24.2 and GSE24.2-NLS1.3 but is less effective on c-myc promoter activation and on the
protection of F9 A353V basal DNA damage. In the same sense, the GSE4-NLS1-DA variant
increases transcriptional activity in F9 and HEK293T cells but is not active in the dyskerin-
mutated F9-A353V cells neither in transcription activation nor in basal DNA damage protec-
tion. These data could indicate that these peptides participate in different cellular processes
through different mechanisms. Some of the variant studied, like GSE4-NLS1-DA could require
the presence of Wild-type dyskerin for some of their activities but other variants and the
unmodified GSE24.2 and GSE4 peptides do not seem to be dependent on dyskerin for any of
their biological activities.
In summary, the eleven amino acids long GSE4 peptide shows a protective effect on dys-
kerin mutated cells similar to the one previously shown for GSE24.2. Protection is mediated by
increased telomerase activity and cell proliferation but also by decreased oxidative stress, DNA
damage and cell senescence. These properties make of GSE4 a good candidate as a drug for
dyskeratosis congenita treatment with some practical advantages over the already approved
GSE24.2 peptide.
Supporting Information
S1 Fig. Cellular localization of the GSE24.2 peptide containing nuclear localization signals
at the N-terminal region. pcDNA3 vectors were generated coding for the GSE24.2 peptide
fused to the NLS1 nuclear localization signal (KRKR) or the NLS2 signal (KKEKKKSKK) fused
to the N-terminal region, named 24.2-NLS1-5 and 24.2-NLS2.5 respectively. The nuclear locali-
zation signals were placed between the N-terminal 6xmyc epitope and the GSE24.2 peptide in
the proteins expressed from these vectors. HeLa cells were transformed with the pcDNA3 vec-
tors expressing GSE24.2, 24.2-NLS1.5 and 24.2-NLS2.5, fixed, permeabilized and incubated with
a c-myc antibody. Immunofluorescence staining was observed after incubation of the prepara-
tions with a secondary antibody conjugated with Alexa fluor 488 using a Nikon 90i microscope.
(PDF)
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